Pages that link to "Q44850143"
Jump to navigation
Jump to search
The following pages link to Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial. (Q44850143):
Displaying 9 items.
- Side effects of HIV therapy (Q29394405) (← links)
- Durability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients with/without prior co-administration of rifampicin: a 144-week prospective study (Q33375532) (← links)
- Comparison of nevirapine plasma concentrations between lead-in and steady-state periods in Chinese HIV-infected patients (Q34566233) (← links)
- Once-daily nevirapine dosing: a pharmacokinetics, efficacy and safety review (Q36738171) (← links)
- Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis (Q39553824) (← links)
- What's new in dermatology and HIV infection in 2004 (Q43520962) (← links)
- [The treatment of HIV infection]. (Q46840347) (← links)
- Cutaneous drug-reactions to nevirapine: study of risk factors in 101 HIV-infected patients (Q46919295) (← links)
- Reacciones de hipersensibilidad a antirretrovirales en pacientes con infección por el virus de la inmunodeficiencia humana (Q58006174) (← links)